HomePHIO • NASDAQ
add
Phio Pharmaceuticals Corp
Previous close
$0.78
Day range
$0.72 - $0.78
Year range
$0.50 - $3.44
Market cap
4.08M USD
Avg Volume
373.35K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 2.21M | 50.48% |
Net income | -2.15M | 40.20% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -2.21M | 38.43% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 6.48M | -28.33% |
Total assets | 6.85M | -29.40% |
Total liabilities | 1.25M | -47.87% |
Total equity | 5.60M | — |
Shares outstanding | 4.59M | — |
Price to book | 0.64 | — |
Return on assets | -68.11% | — |
Return on capital | -82.62% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -2.15M | 40.20% |
Cash from operations | -2.01M | 25.74% |
Cash from investing | — | — |
Cash from financing | -4.00K | 89.47% |
Net change in cash | -2.02M | 26.62% |
Free cash flow | -1.24M | 7.86% |
About
Phio Pharmaceuticals Inc. is a US biotechnology company focused on the field of siRNA. Formerly known as RXi Pharmaceuticals, the company's name was changed to Phio Pharmaceuticals in 2018. Wikipedia
Founded
2011
Headquarters
Website
Employees
9